| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/24/1999 | EP0439542B1 Filamentous hemagglutinin of b. pertussis |
| 02/24/1999 | CN1209169A Process for microbial prodn. of amino acid by boosted activity of export carriers |
| 02/24/1999 | CN1209167A Human chemokine polypeptides |
| 02/24/1999 | CN1209068A Hyaluronic acid as DNA carrier for gene therapy and VEGF antisense DNA to treat abnormal retinal vascularization |
| 02/24/1999 | CN1208769A Synthesis and clone of composite polyvalent vaccine gene for type-C hepatitis virus |
| 02/24/1999 | CN1208731A Recombination human alpha type composite interferon, prepn. method and use therefor |
| 02/24/1999 | CN1208730A Prodn. of human growth hormone by using animal mamma as raw material |
| 02/23/1999 | US5874626 Osmotin gene promoter and use thereof |
| 02/23/1999 | US5874565 Nucleic acids comprising a highly conserved novel 3 terminal sequence element of the hepatitis C virus |
| 02/23/1999 | US5874563 Hepatitis G virus and molecular cloning thereof |
| 02/23/1999 | US5874562 Nucleic acid encoding developmentally-regulated endothelial cell locus-1 |
| 02/23/1999 | US5874561 DNA, host cell and vector encoding a protein with cytokine inhibitory activity |
| 02/23/1999 | US5874560 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 02/23/1999 | US5874557 Enzyme inhibitors which bind to polymerases at ambient temperatures and prevent amplification of nontarget oligonucleotides during polymerase chain reactions; for accurate diagnosis |
| 02/23/1999 | US5874556 Hybrid genes for use in the production of TH -independent cytotoxic T cells |
| 02/23/1999 | US5874553 Phosphonomonoester nucleic acids, process for their preparation, and their use |
| 02/23/1999 | US5874546 Genetically engineered protein having specific amino acid sequence |
| 02/23/1999 | US5874545 DCC antibodies |
| 02/23/1999 | US5874544 Antibodies to APO(A) |
| 02/23/1999 | US5874543 Platelet factor 4; antiinflammatory agent |
| 02/23/1999 | US5874542 Single chain antibodies specific to VEGF receptors |
| 02/23/1999 | US5874541 Immunoglobulin or fragment is modified such that heavy chain variable region have been replaced by specific sequence or amino acids of a heavy chain immunogloblin comprising two heavy polypeptide chain consisting of antigen binding site |
| 02/23/1999 | US5874539 Antibodies to nuclear matrix proteins |
| 02/23/1999 | US5874536 Proteins with Oncostatin M activity and process for their preparation |
| 02/23/1999 | US5874535 Human leptin receptor gene-related protein |
| 02/23/1999 | US5874534 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
| 02/23/1999 | US5874533 HIV-2 envelope polypeptides |
| 02/23/1999 | US5874531 Polypeptides implicated as self epitope in autoimmune disease pemphigus vulgaris and multiple scelerosis |
| 02/23/1999 | US5874529 Conformationally constrained backbone cyclized peptide analogs |
| 02/23/1999 | US5874528 Binding peptides which interact with ligand growth factors of the epidermal growth factor receptor and erbB-2 receptor |
| 02/23/1999 | US5874527 Plasmodium vivax blood stage antigens |
| 02/23/1999 | US5874526 Toxoplasma gondii antigens |
| 02/23/1999 | US5874419 Compositions and methods for modulating growth of a tissue in a mammal |
| 02/23/1999 | US5874414 Trans-splicing ribozymes |
| 02/23/1999 | US5874410 Pentapeptide for treatment of skin disorders |
| 02/23/1999 | US5874409 Antiphospholipid analog specifically binds antibodies produced by b cells specific for an antiphospholipid epitope and lacks t cell epitopes; where in the analog is a oligopeptide or polypeptide |
| 02/23/1999 | US5874408 Stabilized albumin-free recombinant factor VII preparation having a low sugar content |
| 02/23/1999 | US5874407 Administering pharmaceutical composition comprising excipient and fusion protein of factor viia active site inhibitor domain, peptide linker domain, and tissue factor domain to inhibit procoagulant activity; cardiovascular disorders |
| 02/23/1999 | US5874406 Synthetic peptide analogs of lung surface protein SP-C |
| 02/23/1999 | US5874405 Heat shock protein peptides that share sequences with cyclic nucleotide phosphodiesterase and methods for modulating autoimmune central nervous system disease |
| 02/23/1999 | US5874401 Cedar pollen protein and use thereof in treating, preventing, and diagnosing pollenosis |
| 02/23/1999 | US5874400 Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor |
| 02/23/1999 | US5874399 Progenitor B cell stimulating factor |
| 02/23/1999 | US5874308 A first member of a specific binding pair and a conjugate comprising a second member of said specific binding pair and an amino acid sequence comprising a substrate binding region derived from a polysaccharidase |
| 02/23/1999 | US5874304 Humanized green fluorescent protein genes and methods |
| 02/23/1999 | US5874303 Sustainable cell line for the production of Marek's disease vaccines |
| 02/23/1999 | US5874300 Campylobacter jejuni antigens and methods for their production and use |
| 02/23/1999 | US5874299 Transgene coding for human immunoglobulin heavy chain variable regions, d regions, j regions, mu constant region, and gamma constant region where gamma region is closer to mu region than in natural locus |
| 02/23/1999 | US5874298 Wasp neurotoxin for controlling heliothis virescens (tobacco budworm); fast acting, insects stop feeding quickly; low toxicity to mammals; host cells and vectors expressing toxin |
| 02/23/1999 | US5874290 Nucleotide and amino acid sequences of a D2-2 gene associated with brain tumors and methods based thereon |
| 02/23/1999 | US5874288 Bacillus thuringiensis toxins with improved activity |
| 02/23/1999 | US5874287 Mutagenized DNA molecules encoding modified subunit a of Cholera-toxin |
| 02/23/1999 | US5874286 Tumor proteins |
| 02/23/1999 | US5874280 Mutant comprising insertion of heterologous dna sequence in section of bhv-1 genome and inserted polyadenylation signal |
| 02/23/1999 | US5874279 Recombinant infectious bovine rhinotracheitis virus |
| 02/23/1999 | US5874267 Expression of surface layer proteins |
| 02/23/1999 | US5874265 Methods and compositions for the production of stably transformed fertile monocot plants and cells thereof |
| 02/23/1999 | US5874264 Retrovirus |
| 02/23/1999 | US5874254 FGF-5 analogous protein, and pharmaceutical composition containing the same |
| 02/23/1999 | US5874253 Expression vectors and genetic engineering |
| 02/23/1999 | US5874252 Splicing variant of the Epstein-Barr virus-induced G-protein coupled receptor |
| 02/23/1999 | US5874251 DNA encoding the Taenia crassiceps ten kilodalton antigen |
| 02/23/1999 | US5874250 DNA encoding for a protein containing the extracellular domain of lymphocyte activation gene 3 |
| 02/23/1999 | US5874248 Polynucleotides and codes |
| 02/23/1999 | US5874247 Protein disulfide isomerase and method of using |
| 02/23/1999 | US5874246 Transcription repressor |
| 02/23/1999 | US5874245 Human G-protein coupled receptor (HIBCD07) |
| 02/23/1999 | US5874243 OLRCC15 receptor |
| 02/23/1999 | US5874241 Clock gene and gene product |
| 02/23/1999 | US5874240 Human 4-1BB receptor splicing variant |
| 02/23/1999 | US5874238 A dna molecule encoding a mutant mammalian c-reactive protein which has at least one cysteine deleted or replaced by other amino acid, for binding aggregated immunoglobulin and immune complexes, treating infections, endotoxic shock, cancer |
| 02/23/1999 | US5874236 DNA encoding human calcium channel α-1A, β1, β-2, and β-4 subunits, and assays using cells that express the subunits |
| 02/23/1999 | US5874234 Assay for a novel mammalian protein associated with uncontrolled cell division |
| 02/23/1999 | US5874230 Tumor necrosis factor receptor and dna codes |
| 02/23/1999 | US5874228 Methods and kits for determining the levels of IGE-BF |
| 02/23/1999 | US5874227 Binds to corticotropin factor; competitive binding assay for screening ligands |
| 02/23/1999 | US5874225 Cell line from human rhabdomyosarcoma cell line te671. differentiated cells are characterized by great enlargement |
| 02/23/1999 | US5874224 Growth factor receptor binding protein |
| 02/23/1999 | US5874221 Species specific method for the PCR detection of phythophthora |
| 02/23/1999 | US5874220 Primers for the amplification of genes coding for the enterotoxin and the lecithinase of Clostridium perfringens and their application to the detection and numeration of these bacteriae |
| 02/23/1999 | US5874218 Method for detecting a target compound in a substance using a nucleic acid ligand |
| 02/23/1999 | US5874211 Chemokine expressed in eosinophils |
| 02/23/1999 | US5874210 Genes determining cellular senescence in yeast |
| 02/23/1999 | US5874209 Regulation of transcription factor, NF-IL6/LAP |
| 02/23/1999 | US5874089 Protecting against canine oral papillomavirus (copy) |
| 02/23/1999 | US5874088 Oral cholera vaccine from vibrio cholerae |
| 02/23/1999 | US5874087 Modified plant viruses as vectors |
| 02/23/1999 | US5874086 Synthetic polypeptide analogs of parathyroid hormone (pth), parathyroid hormone related peptide (pthrp), and of the physiologically active truncated homologs and analogs of pth and pthrp; forming an amphipathic alpha-helix |
| 02/23/1999 | US5874085 A drug comprising at least one cytokine stimulants and a b cell activator selected from a cell surface protein and bacterial lipopolysaccharide |
| 02/23/1999 | US5874083 Proteins and complexes for immune response |
| 02/23/1999 | US5874082 Humanized anti-CD40 monoclonal antibodies and fragments capable of blocking B cell proliferation |
| 02/23/1999 | US5874077 Human til cells expressing recombinant TNF prohormone |
| 02/23/1999 | US5874076 Immunomodulators; antitumor,-carcinogenic agents; extracted from a recombinant microorganism; separated from reduced interleukin (cysteine) from the oxidized interleukin (cystine) |
| 02/23/1999 | US5874075 Stable protein: phospholipid compositions and methods |
| 02/23/1999 | CA2050941C Antibody to smooth muscle myosin heavy chains |
| 02/23/1999 | CA1340401C Cell surface protein, process for its preparation, and the use of a cell surface protein thus obtained |
| 02/20/1999 | CA2241429A1 Cxcr4b: a human splice variant of cxcr4 chemokine receptor |
| 02/19/1999 | CA2245310A1 Sca7 gene and methods of use |
| 02/19/1999 | CA2241433A1 Novel compounds |
| 02/19/1999 | CA2240631A1 Pigr-1, a member of immunoglobulin gene superfamily |